Cubist Systematic Strategies, LLC Protagonist Therapeutics, Inc Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 84,202 shares of PTGX stock, worth $3.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

84,202

Previous 84,202 -0.0%

Holding current value

$3.78 Million

Previous $2.92 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.66 - $34.8 $1.93 Million - $2.72 Million	78,207 Added 1304.54%	84,202 $2.92 Million
Q1 2024 May 15, 2024	BUY	$21.79 - $32.15 $130,631 - $192,739	5,995 New	5,995 $173,000
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $145,228 - $341,919	13,472 Added 26.16%	64,978 $1.49 Million
Q4 2022 Feb 14, 2023	BUY	$7.36 - $11.17 $239,030 - $362,768	32,477 Added 170.67%	51,506 $561,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $25.52 $64,295 - $232,410	-9,107 Reduced 32.37%	19,029 $151,000
Q1 2022 May 16, 2022	BUY	$23.34 - $36.08 $643,950 - $995,447	27,590 Added 5053.11%	28,136 $666,000
Q4 2021 Feb 14, 2022	SELL	$17.63 - $37.1 $10,066 - $21,184	-571 Reduced 51.12%	546 $19,000
Q3 2021 Nov 15, 2021	SELL	$12.95 - $49.69 $36,039 - $138,287	-2,783 Reduced 71.36%	1,117 $20,000
Q2 2021 Aug 16, 2021	SELL	$25.57 - $44.88 $276,156 - $484,704	-10,800 Reduced 73.47%	3,900 $175,000
Q1 2021 May 17, 2021	BUY	$19.02 - $31.15 $279,594 - $457,905	14,700 New	14,700 $381,000
Q3 2020 Nov 16, 2020	SELL	$15.19 - $22.4 $335,471 - $494,703	-22,085 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.19 - $18.84 $136,706 - $416,081	22,085 New	22,085 $390,000
Q4 2019 Feb 14, 2020	SELL	$4.69 - $13.45 $103,142 - $295,792	-21,992 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$9.41 - $16.56 $206,944 - $364,187	21,992 New	21,992 $264,000
Q2 2018 Aug 14, 2018	SELL	$5.99 - $9.1 $69,442 - $105,496	-11,593 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.46 - $23.08 $70,446 - $192,187	8,327 Added 254.96%	11,593 $100,000
Q4 2017 Feb 14, 2018	BUY	$14.47 - $20.8 $47,259 - $67,932	3,266	3,266 $68,000

Others Institutions Holding PTGX

# of Institutions

195

Shares Held

58.7M

Call Options Held

20.8K

Put Options Held

109K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.21B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Protagonist Therapeutics, Inc Transaction History